Chromon-3-aldehyde derivatives restore mitochondrial function in rat cerebral ischemia

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Brain ischemia, such as stroke, causes significant mitochondrial dysfunction.
• Mitochondrial dysfunction is a key factor in neuronal cell death and neurological deficits.
• Developing effective therapeutic agents to protect mitochondria during ischemia is crucial.

Purpose of the Study:

• To evaluate the efficacy of ten novel chromon-3-aldehyde derivatives.
• To assess their impact on mitochondrial function following induced brain ischemia in a rat model.
• To identify derivatives with potential neuroprotective properties.

Main Methods:

• Cerebral ischemia was induced in male Wistar rats via permanent middle cerebral artery occlusion.
• Rats were treated with ten chromon-3-aldehyde derivatives or N-acetylcysteine for three days post-ischemia.
• Neurological symptoms, infarct size, and mitochondrial function (ATP generation, respiration, apoptosis, membrane potential) were assessed.

Main Results:

• All tested chromon-3-aldehyde derivatives promoted mitochondrial function recovery, enhancing ATP generation and respiration.
• These derivatives reduced anaerobic reactions, apoptosis, and normalized mitochondrial membrane potential.
• The 6-acetyl substituted derivative demonstrated the most significant improvements, decreasing neurological deficits and brain necrosis area.

Conclusions:

• The 6-acetyl substituted chromon-3-aldehyde derivative exhibits potent neurotropic effects.
• Its mechanism involves the restoration of mitochondrial function.
• This derivative warrants further investigation as a potential therapeutic agent for ischemic brain injury.